141 related articles for article (PubMed ID: 12756432)
1. Cold-Eeze lozenge for common colds.
Eby G
Am J Ther; 2003; 10(3):233; author reply 233-4. PubMed ID: 12756432
[No Abstract] [Full Text] [Related]
2. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects.
McElroy BH; Miller SP
Am J Ther; 2003; 10(5):324-9. PubMed ID: 12975716
[TBL] [Abstract][Full Text] [Related]
3. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.
Eby GA; Davis DR; Halcomb WW
Antimicrob Agents Chemother; 1984 Jan; 25(1):20-4. PubMed ID: 6367635
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) against the common cold in school-aged subjects: a retrospective chart review.
McElroy BH; Miller SP
Am J Ther; 2002; 9(6):472-5. PubMed ID: 12424502
[TBL] [Abstract][Full Text] [Related]
5. Sugar-free zinc gluconate glycine lozenges (Cold-Eeze) do not adversely affect glucose control in patients with type 1 or type 2 diabetes mellitus.
Schwartz SL; Fischer JS; Kipnes MS
Am J Ther; 2001; 8(4):247-52. PubMed ID: 11441324
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of intranasal zinc gluconate.
Yiu SC
Clin Infect Dis; 2002 Jun; 34(12):1657. PubMed ID: 12032907
[No Abstract] [Full Text] [Related]
7. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.
Farr BM; Conner EM; Betts RF; Oleske J; Minnefor A; Gwaltney JM
Antimicrob Agents Chemother; 1987 Aug; 31(8):1183-7. PubMed ID: 2820298
[TBL] [Abstract][Full Text] [Related]
8. Zinc for the common cold.
Godfrey JC
Antimicrob Agents Chemother; 1988 Apr; 32(4):605-6. PubMed ID: 3377471
[No Abstract] [Full Text] [Related]
9. Zinc gluconate lozenges for common cold. A double-blind clinical trial.
Weismann K; Jakobsen JP; Weismann JE; Hammer UM; Nyholm SM; Hansen B; Lomholt KE; Schmidt K
Dan Med Bull; 1990 Jun; 37(3):279-81. PubMed ID: 2192839
[TBL] [Abstract][Full Text] [Related]
10. Stability constants of zinc complexes affect common cold treatment results.
Eby GA
Antimicrob Agents Chemother; 1988 Apr; 32(4):606-7. PubMed ID: 3377472
[No Abstract] [Full Text] [Related]
11. Safety of zinc gluconate glycine (Cold-Eeze) in a geriatric population: a randomized, placebo-controlled, double-blind trial.
Silk R; LeFante C
Am J Ther; 2005; 12(6):612-7. PubMed ID: 16280656
[TBL] [Abstract][Full Text] [Related]
12. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial.
Eby GA; Halcomb WW
Altern Ther Health Med; 2006; 12(1):34-8. PubMed ID: 16454145
[TBL] [Abstract][Full Text] [Related]
13. Zinc gluconate lozenges for treating the common cold.
Evans MF; Frank J
Can Fam Physician; 1997 Mar; 43():453. PubMed ID: 9882105
[No Abstract] [Full Text] [Related]
14. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial.
Macknin ML; Piedmonte M; Calendine C; Janosky J; Wald E
JAMA; 1998 Jun; 279(24):1962-7. PubMed ID: 9643859
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of zinc against common cold viruses: an overview.
Hulisz D
J Am Pharm Assoc (2003); 2004; 44(5):594-603. PubMed ID: 15496046
[TBL] [Abstract][Full Text] [Related]
16. The role of zinc lozenges in treatment of the common cold.
Garland ML; Hagmeyer KO
Ann Pharmacother; 1998 Jan; 32(1):63-9. PubMed ID: 9475824
[TBL] [Abstract][Full Text] [Related]
17. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.
Mossad SB; Macknin ML; Medendorp SV; Mason P
Ann Intern Med; 1996 Jul; 125(2):81-8. PubMed ID: 8678384
[TBL] [Abstract][Full Text] [Related]
18. Zinc for colds? Yes, but don’t swallow whole!
Eby G
J Fam Pract; 2012 Jan; 61(1):9; author reply 9-10. PubMed ID: 22389935
[No Abstract] [Full Text] [Related]
19. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.
Al-Nakib W; Higgins PG; Barrow I; Batstone G; Tyrrell DA
J Antimicrob Chemother; 1987 Dec; 20(6):893-901. PubMed ID: 3440773
[TBL] [Abstract][Full Text] [Related]
20. Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials.
Hemilä H
BMC Med Res Methodol; 2017 May; 17(1):82. PubMed ID: 28494765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
